Monopar Therapeutics (MNPR) Institutional Ownership $35.35 -0.21 (-0.59%) As of 11:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Monopar Therapeutics (NASDAQ:MNPR)CurrentInstitutional OwnershipPercentage1.83%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$58.48MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.07M Get MNPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Monopar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MNPR Institutional Buying and Selling by Quarter Monopar Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Jane Street Group LLC10,357$377K0.0%N/A0.169% 5/16/2025 Goldman Sachs Group Inc.18,480$673K0.0%N/A0.302% 5/16/2025 ADAR1 Capital Management LLC100,774$3.67M0.7%-22.5%1.648% 5/15/2025 OMERS ADMINISTRATION Corp9,000$328K0.0%N/A0.147% 5/14/2025 Affinity Asset Advisors LLC62,000$2.26M0.2%N/A1.014% 5/14/2025 AlphaQuest LLC1,215$44K0.0%N/A0.020% 4/23/2025 Gerber LLC5,601$204K0.2%N/A0.092% 2/17/2025 Point72 Asset Management L.P.167,892$3.69M0.0%N/A2.752% 2/17/2025 Janus Henderson Group PLC1,046,899$23.44M0.0%N/A17.162% 2/14/2025 RA Capital Management L.P.511,207$11.25M0.1%N/A8.380% 2/14/2025 Adage Capital Partners GP L.L.C.599,195$13.18M0.0%N/A9.823% 2/13/2025 ADAR1 Capital Management LLC130,037$2.86M0.6%N/A2.132% 2/12/2025 Geode Capital Management LLC38,596$849K0.0%+174.4%0.633% 2/12/2025 JPMorgan Chase & Co.2,037$45K0.0%N/A0.033% 10/31/2023 Windsor Advisory Group LLC89,974$56K0.1%N/A0.635% 8/13/2021 Geode Capital Management LLC28,761$169K0.0%+9.0%0.229% 8/13/2021 Vanguard Group Inc.97,462$574K0.0%+116.2%0.775% 5/21/2021 Citadel Advisors LLC12,479$77K0.0%N/A0.099% 5/18/2021 Citadel Advisors LLC12,479$77K0.0%N/A0.099% 5/17/2021 Royal Bank of Canada9,130$57K0.0%N/A0.073% 5/12/2021 Northern Trust Corp36,001$223K0.0%-38.8%0.286% 5/12/2021 Geode Capital Management LLC26,394$163K0.0%N/A0.210% 5/7/2021BlackRock Inc.11,229$70K0.0%+108.3%0.089% (Data available from 1/1/2016 forward) MNPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MNPR shares? During the previous two years, 14 institutional investors and hedge funds held shares of Monopar Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($23.44M), Adage Capital Partners GP L.L.C. ($13.18M), RA Capital Management L.P. ($11.25M), Point72 Asset Management L.P. ($3.69M), ADAR1 Capital Management LLC ($3.67M), Affinity Asset Advisors LLC ($2.26M), and Geode Capital Management LLC ($849K).Learn more on MNPR's institutional investors. What percentage of Monopar Therapeutics stock is owned by institutional investors? 1.83% of Monopar Therapeutics stock is owned by institutional investors. Learn more on MNPR's institutional investor holdings. Which institutional investors have been buying Monopar Therapeutics stock? Of the 14 institutional investors that purchased Monopar Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($1.05M), Adage Capital Partners GP L.L.C. ($599.20K), RA Capital Management L.P. ($511.21K), Point72 Asset Management L.P. ($167.89K), ADAR1 Capital Management LLC ($130.04K), Windsor Advisory Group LLC ($89.97K), and Affinity Asset Advisors LLC ($62K). How much institutional buying is happening at Monopar Therapeutics? Institutional investors have bought a total of 2,678,424 shares in the last 24 months. This purchase volume represents approximately $58.76M in transactions. Which Monopar Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Monopar Therapeutics stock in the last 24 months: ADAR1 Capital Management LLC ($29.26K). How much institutional selling is happening at Monopar Therapeutics? Institutional investors have sold a total of 29,263 shares in the last 24 months. This volume of shares sold represents approximately $1.07M in transactions. Related Companies Spyre Therapeutics Major Shareholders Pharvaris Major Shareholders CureVac Major Shareholders CorMedix Major Shareholders Bicara Therapeutics Major Shareholders Enliven Therapeutics Major Shareholders Zymeworks Major Shareholders uniQure Major Shareholders Chimerix Major Shareholders LENZ Therapeutics Major Shareholders This page (NASDAQ:MNPR) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MNPR Stock Free MNPR Stock Alerts